20/20 Biolabs Inc 2026年季度报告

NOTE 1—BASIS OF PRESENTATION AND OTHER INFORMATION The accompanying unaudited condensed financial statements of 20/20 Biolabs, Inc. (the “Company”) have been prepared inaccordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial informationand with the instructions to Form 10-Q and Regulation S-X. They do not include all the information and footnotes required by GAAPfor complete financial statements. The March 31, 2026 balance sheet data was derived from audited financial statements but do notinclude all disclosures required by GAAP. The unaudited condensed financial statements should be read in conjunction with thosefinancial statements included in the Company’s Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on March Significant Accounting Policies The Company’s significant accounting policies are disclosed in the audited financial statements as of and for the year ended December31, 2025, and notes thereto, which are included in the Form 10-K. Since the date of those financial statements, there have been no Preferred Stock– The Company’s series E convertible preferred stock is recorded outside of stockholders’ equity (deficit) because, inthe event of certain deemed liquidation events, which are events that are not considered solely within the Company’s control, the series Warrants– Warrants are accounted for as either equity or liability-classified based on ASC 480 and ASC 815. The warrant described inNote 10 is classified as equity and has been included in additional paid-in capital within stockholders’ equity (deficit). Recent Accounting Pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or otherstandard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of InNovember 2024,the FASB issued the ASC 2024-03,Income Statement-Reporting Comprehensive Income-ExpenseDisaggregation Disclosures (Subtopic 220-04) Disaggregation of Income Statement Expenses, which requires additional disclosure ofthe nature of expenses included in the income statement in response to requests from investors for more information about an entity’sexpenses. The new standard requires disclosures about specific types of expenses included in the expense captions presented on the NOTE 2—LIQUIDITY AND GOING CONCERN ASSESSMENT Management assesses liquidity and going concern uncertainty in the Company’s condensed financial statements to determine whetherthere is sufficient cash on hand and working capital, including available borrowings on loans, to operate for a period of at least oneyear from the date the financial statements are issued, which is referred to as the “look-forward period,” as defined in GAAP. As partof this assessment, based on conditions that are known and reasonably knowable to management, management considered variousscenarios, forecasts, projections, estimates and made certain key assumptions, including the timing and nature of projected cash As of March 31, 2026, the Company had cash and cash equivalents of $4,219,099 and a total working capital of $2,120,232. For thethree months ended March 31, 2026, the Company incurred an operating loss of $1,443,356 and cash flows used in operating activities The Company has incurred recent operating losses, which management anticipates may continue in the near term. To support ongoingoperations and liquidity needs, the Company has raised additional funding through a private placement of $5 million during the current The accompanying condensed financial statements have been prepared assuming the Company will continue as a going concern,which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The accompanyingcondensed financial statements do not include any adjustments relating to the recoverability and classification of assets and their NOTE 3—DISAGGREGATION OF REVENUE AND CONTRACT LIABILITIES Disaggregated Revenue The Company disaggregates revenue from contracts with customers by contract type, as it believes it best depicts how the nature,amount, timing and uncertainty of revenue and cash flows are affected by economic factors. The Company’s revenue by contract type Contract Liabilities Deferred revenue represents contract liabilities that are recorded when cash payments are received or are due in advance of theCompany’s satisfaction of performance obligations. The deferred revenue as of March 31, 2026 and December 31, 2025 was $487,722 The following table provides information about contract liabilities from contracts with customers as of March 31, 2026 and December31, 2025. LiabilitiesBalance, December 31, 2025$456,687 NOTE 4—PROPERTY AND EQUIPMENT Property and equipment as of March 31, 2026 and December 31, 2025 consisted of the following: Depreciation expense for the three months